Fundraising Fox
/Companies
Sign in

Vianovatx

Oakland, US · Founded 2020 · Delaware corporation · 2 known investors

Find your way into Vianovatx

Sign up to see every warm intro you have to Vianovatx

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Vianovatx team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Via Nova develops antiviral therapies targeting acute and subacute viral infections, including respiratory, gastrointestinal, and neurological infections. The company focuses on infections with high prevalence and severe illness potential, serving patients with unmet treatment needs across multiple viral categories.

BiotechDigital HealthMedical Devices

Founders & leadership

DG
Donald GanemNamed on SEC filing
BL
Benjamine LiuNamed on SEC filing
IZ
Ilan ZipkinNamed on SEC filingGeneral Partner at Aditum Bio

Board

JJJoseph Jimenez
Joseph JimenezBoard directorInvestor at Aditum Bio

Investors · 2

PMVlisted by PMVBrussels

How we know: PMV's portfolio page · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$5M disclosed across 1 round · 2021

▶$5MraisedSep 2021 · 2 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Donald GanemExecutive Officer, Director
  • Joseph JimenezDirector
  • Benjamine LiuDirector
  • Ilan ZipkinDirector
Offering amount
$5M
Amount sold
$5M
First sale
Aug 2021
Incorporated
Corporation, Delaware, 2020
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 3

Vianova SASVianova operates a cloud-based intelligence platform that aggregates and combines mobility data from multiple sources, letting cities and businesses analyze insights and automate decisions. It also runs a data exchange with over 1,000 mobility data sources and offers integration, project management, and advisory services for urban mobility use cases.
OsmosisOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
MedscapeMedscape is an online platform providing medical news, clinical information, and continuing education resources to physicians and healthcare professionals globally. The platform offers CME courses, drug and disease information, and patient education across multiple specialties.

Companies working in the same space as Vianovatx.

Frequently asked questions

What does Vianovatx do?
Via Nova develops antiviral therapies targeting acute and subacute viral infections, including respiratory, gastrointestinal, and neurological infections. The company focuses on infections with high prevalence and severe illness potential, serving patients with unmet treatment needs across multiple viral categories.
Who are Vianovatx's investors?
Vianovatx's investors include Aditum Bio, PMV.
How much funding has Vianovatx raised?
Vianovatx has disclosed $5M raised across 1 round.
Where is Vianovatx headquartered?
Vianovatx is headquartered in Oakland, US.